Condensec Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenue	$ 32,166	$ 0	$ 49,483	$ 0
Cost of revenue	7,493	0	14,104	0
Gross profit	24,673	0	35,379	0
Operating expenses:
Selling, general and administrative	593,262	34,220	864,286	159,179
Research and development	271,935	0	271,935	0
Expenses incurred on terminated acquisition	20,433	108,858	170,259	108,858
Total operating expenses	885,630	143,078	1,306,480	268,037
Loss from operations	(860,957)	(143,078)	(1,271,101)	(268,037)
Other income (expense):
Interest expense	(223,008)	(216,311)	(433,595)	(424,368)
Gain on expiration of accrued tax liability	1,276,837	0	1,276,837	0
Gain (loss) on foreign exchange	(4,412)	0	(4,412)	0
Total other income (expenses)	1,049,417	(216,311)	838,830	(424,368)
Net loss before taxes	188,460	(359,389)	(432,271)	(692,405)
Income taxes	0	0	0	0
Net income (loss)	188,460	(359,389)	(432,271)	(692,405)
Foreign currency translation	2,100	0	2,100	0
Comprehensive loss	$ 190,560	$ (359,389)	$ (430,171)	$ (692,405)
Net loss per share - basic	$ 0.00	$ (0.01)	$ (0.01)	$ (0.01)
Net loss per share - diluted	$ 0.00	$ (0.01)	$ (0.01)	$ (0.01)
Weighted average common shares outstanding - basic	49,943,628	47,281,128	49,112,378	47,281,128
Weighted average common shares outstanding - diluted	105,711,091	47,281,128	49,112,378	47,281,128